SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act 1934

Date of Report (date of earliest event reported): September 22, 2006


                                  Hemcure, Inc.
               (Exact name of registrant as specified in charter)

                                     Nevada
                 (State or other jurisdiction of incorporation)


         005-80848                                      20-5573204
   ----------------------                        -------------------------
   (Commission File Number)                 (IRS Employer Identification No.)



          730 W. Randolph
            Suite 600
          Chicago, Illinois                               60661
   --------------------------------                   --------------
(Address of principal executive offices)                (Zip Code)


                                 (312) 454-0015
                           ---------------------------
                           (Issuer's Telephone Number)


                                 Not applicable.
                 -----------------------------------------------
          (Former name or former address, if changed since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing  obligation  of  registrant  under any of the
following provisions:

|_| Written  communications  pursuant to Rule 425  under the  Securities Act (17
    CFR 230.425)



|_| Soliciting  material pursuant to  Rule 14a-12(b)  under the Exchange Act (17
    CFR 240.14a-12(b))

|_| Pre-commencement   communications   pursuant  to  Rule  14d-2(b)  under  the
    Exchange Act (17 CFR 240.14d-2(b))

|_| Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under   the
    Exchange Act (17 CFR 240.13e-4(c))


ITEM 8.01. OTHER EVENTS

At the  opening of  business  on  September  22,  2006,  the  reverse  split and
reincorporation  of  Hemcure,  Inc.  took  effect.  The new  trading  symbol for
Hemcure, Inc. on the Over the Counter Bulletin Board is now HMCU.

The  Agreement  and Plan of  Merger  set  forth  the  following:  1) a change in
domicile from the State of Minnesota to the State of Nevada;  2) the adoption of
the Articles of  Incorporation  of Hemcure Nevada under the laws of the state of
Nevada (as  provided  in the proxy  materials);  3) the  issued and  outstanding
shares of common stock of Hemcure Minnesota automatically convert into the right
to receive  shares of Hemcure  Nevada  Common Stock at a ratio of seventeen  and
one-half (17.5) shares of common stock of Hemcure Minnesota for one (1) share of
Hemcure  Nevada  Common Stock;  4) the adoption of the bylaws of Hemcure  Nevada
under the laws of the state of Nevada (as provided in the proxy materials);  and
5) the persons presently serving as executive  officers and directors of Hemcure
Minnesota serve in their same respective positions with Hemcure Nevada.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

     (d)  Exhibits
          None.

                                   SIGNATURES


         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                  HEMCURE, INC.


                              By /s/ Bartly Loethen
                                 -----------------------------------------
                              Name:  Bartly Loethen
                              Title: Chief Executive Officer and President

Dated: September 26, 2006